You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,777,007


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,777,007 protect, and when does it expire?

Patent 9,777,007 protects BYFAVO and is included in one NDA.

This patent has thirty-two patent family members in nineteen countries.

Summary for Patent: 9,777,007
Title:Short-acting benzodiazepine salts and their polymorphic forms
Abstract: The invention relates to besylate salts of the compound of formula (I): ##STR00001## Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
Inventor(s): Tilbrook; Gary Stuart (Huntingdon, GB), Quegan; Louisa Jane (Cambridge, GB)
Assignee: PAION UK LIMITED (GB)
Application Number:14/948,889
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,777,007: A Detailed Analysis

Introduction

Patent 9,777,007, like any other patent, is a complex document that outlines the invention, its scope, and the claims that define the legal boundaries of the invention. To understand this patent, it is crucial to delve into its various components, including the specification, drawings, and most importantly, the claims.

The Specification

The specification of a patent is a detailed written description of the invention. It includes discussions of prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. For Patent 9,777,007, the specification would provide a comprehensive overview of the invention, explaining its components, how it works, and its advantages over existing technologies[4].

The Drawings

The drawings section of the patent contains illustrations of the technical details of the invention. These drawings are essential for visualizing the invention and understanding its structural and functional aspects. In the case of Patent 9,777,007, the drawings would help in identifying the key components and their interactions[4].

The Claims

The claims are the most critical part of a patent as they define the scope of protection for the invention. Here is a detailed look at what claims entail and how they apply to Patent 9,777,007.

What are Claims?

Claims are paragraphs located at the end of the specification that define the legal boundaries of the invention. They must be clear, concise, and fully supported by the description provided in the specification. The claims specify what the inventor is seeking protection for[4][5].

Types of Claims

There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim[5].

Claim Structure

Each claim in a patent, including those in Patent 9,777,007, follows a specific structure. For example:

  • Independent Claim: "A portable electronic device, comprising: a first housing; a second housing coupled to the first housing and movable relative thereto between a closed position and an open position; an antenna positioned in the first housing; a low frequency shield coupled to the antenna and adapted to inhibit changes to the frequency response of the antenna when the portable electronic device is moved between the open position and the closed position; and a high frequency chassis resonator coupled to the low frequency shield and adapted to increase high frequency sensitivity of the antenna."
  • Dependent Claim: "The portable electronic device of claim 1, wherein the high frequency chassis resonator is made of a conductive material."

Claim Requirements

Claims must adhere to specific requirements:

  • Clarity and Conciseness: Claims must be clear and concise to avoid ambiguity.
  • Support by Description: Claims must be fully supported by the description in the specification.
  • Reasonable Number: The number of claims should be reasonable considering the nature of the invention[5].

Patent Eligibility and Recent Guidance

The patent eligibility of claims, especially those related to AI and software, has been a subject of significant discussion. The 2024 USPTO guidance update provides clarity on this matter.

Evaluating Practical Applications

The update emphasizes the importance of evaluating whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter. For example, if a claim merely uses a mathematical model to manipulate data without a specific application, it may not be patent-eligible. However, if the claim specifies the use of the data in a real-world application, such as improving speech recognition, it could be considered patent-eligible[1].

AI-Assisted Inventions

The 2024 guidance also clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This means that as long as there is significant human contribution and the invention meets the criteria for patent eligibility, it can be patented regardless of the role of AI in its development[1].

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics can provide insights into the breadth and clarity of the patent claims. Narrower claims are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Real-World Applications and Practical Utility

Demonstrating real-world applications and practical utility is crucial for bolstering the argument for patent eligibility. Claims that specify how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field are more likely to be considered patent-eligible. For instance, a claim that improves the accuracy of voice commands in hands-free environments by using separated audio components in a speech recognition system would be considered to have practical utility[1].

Enablement Requirement

The enablement requirement under 35 U.S.C. ยง 112(a) mandates that the patent specification must describe the invention in sufficient detail so that anyone of ordinary skill in the same technical field can understand and practice the invention. This requirement ensures that the patent provides meaningful disclosure and does not overly broaden the scope of protection[2][4].

Conclusion

Understanding the scope and claims of a patent like United States Patent 9,777,007 involves a thorough analysis of its specification, drawings, and claims. The recent USPTO guidance on AI and software patents provides valuable insights into how to draft claims that are more likely to be considered patent-eligible. By focusing on practical applications, ensuring significant human contribution, and demonstrating real-world utility, inventors can strengthen their patent applications.

Key Takeaways

  • Clear and Concise Claims: Claims must be clear, concise, and fully supported by the specification.
  • Practical Applications: Claims must integrate judicial exceptions into practical applications to be considered patent-eligible.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility.
  • Real-World Utility: Demonstrating real-world applications and practical utility is crucial for patent eligibility.
  • Enablement Requirement: The specification must enable anyone of ordinary skill in the field to practice the invention.

FAQs

Q: What is the primary purpose of the claims in a patent? A: The primary purpose of the claims in a patent is to define the legal boundaries of the invention and specify what the inventor is seeking protection for.

Q: How does the 2024 USPTO guidance update impact AI-related patent claims? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates a judicial exception into a practical application.

Q: What is the enablement requirement in patent law? A: The enablement requirement mandates that the patent specification must describe the invention in sufficient detail so that anyone of ordinary skill in the same technical field can understand and practice the invention.

Q: How can the scope of a patent be measured? A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which provide insights into the breadth and clarity of the patent claims.

Q: Why is it important to demonstrate real-world applications in patent claims? A: Demonstrating real-world applications and practical utility is crucial for bolstering the argument for patent eligibility, as it shows how the abstract idea is applied in a way that provides concrete benefits or solves specific problems.

Sources

  1. Mintz, "Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility"
  2. Supreme Court of the United States, "Amicus Brief"
  3. SSRN, "Patent Claims and Patent Scope"
  4. Queens University Library, "How to Read a U.S. Patent"
  5. USPTO, "The Claims - USPTO"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,777,007

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acacia BYFAVO remimazolam besylate POWDER;INTRAVENOUS 212295-001 Oct 6, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,777,007

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0613692.3Jul 10, 2006
United Kingdom0613694.9Jul 10, 2006

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.